Back

Cardiac magnetic resonance feature tracking identifies preclinical abnormalities in hypertrophic cardiomyopathy sarcomere gene mutation carriers

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Myocardial disease - clinical 7 Hypertrophic Cardiomyopathy HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Francesco Negri

Hospital Santa Maria della Misericordia, Udine (Italy)

7 More presentations in this session

Presentation thumbnail
Identification of a novel actin gene mutation, ACTC1 p.Asn94Ile, in a family with cardiomyopathy and conduction disease
Doctor R. Sepp (Szeged, HU)
Abstract Slides Video
Presentation thumbnail
Refining the diagnosis of hypertrophic cardiomyopathy with a machine learning-based radiomics model: a cardiovascular magnetic resonance study
Doctor I. Miranda (Amadora, PT)
Abstract Slides Video
Presentation thumbnail
Different exercise hemodynamic profiles in obstructive and nonobstructive hypertrophic cardiomyopathy: importance of unmasking diastolic dysfunction
Doctor C. Baratto (Bergamo, IT)
Abstract Slides Video
Presentation thumbnail
Unraveling the complexity of hypertrophic cardiomyopathy: a machine learning-based radiomics model to predict phenotype and cardiovascular events
Doctor I. Miranda (Amadora, PT)
Abstract Slides Video
Presentation thumbnail
Machine-learning based radiomics model to predict ventricular arrythmias in patients with hypertrophic cardiomyopathy
Doctor M. Marques Antunes (Lisboa, PT)
Abstract Slides

Access the full session

Session thumbnail
Myocardial disease - clinical 7

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
Sarcomere-negative hypertrophic cardiomyopathy: clinical characteristics, management, and outcomes
thumbnail
Congress Presentation
Assessment of Myocardial Work in sarcomere gene mutation carriers and overt hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Prognostic role of the progression of late gadolinium enhancement in hypertrophic cardiomyopathy.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources